Back to UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

KNSAKNSA
8 quarters

Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in KINIKSA PHARMACEUTICALS INTL

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 2,790 shares of KNSA (KINIKSA PHARMACEUTICALS INTL), worth $178,421 as of 2026-Q2. The position was decreased (-93.7% shares).

Current Value

$178,421

Current Shares

2,790

Total Value Change

-$926,861

Total Shares Change

-41,439

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2,790
-93.7%
$178,4210.0%$63.95
0
2026-Q1
Increased
44,525
+5.0%
$2.1M0.0%$45.37
27
2025-Q4
Decreased
42,402
-23.6%
$1.7M0.0%$40.99
0
2025-Q3
Decreased
55,519
-47.0%
$2.2M0.0%$38.77
0
2025-Q2
Increased
104,705
+87.0%
$2.9M0.0%$28.04
41
2025-Q1
Decreased
55,976
-1.3%
$1.2M0.0%$23.09
0
2024-Q4
Increased
56,691
+28.2%
$1.1M0.0%$19.60
31
2024-Q3
New
44,229
-
$1.1M0.0%$25.00
35

Other major holders of KNSA: FMR LLC, BAKER BROS. ADVISORS LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used